The absence of opthalmic effects in the assumed GOF mutation carriers is in line with previous studies, showing that KERA mutations are not identified in subjects suffering from cornea plane type 1 (CP1), the autosomal dominant form of cornea plana [29]. This evidence concerns the gene KERA and cornea plana.